Short answer: No, aspirin does not diminish or otherwise alter the cholesterol‑lowering (particularly triglyceride‑lowering) effect of Vascepa (icosapent ethyl).
---
Why they’re independent
| Drug | Primary action | How it works on lipids | Interaction with the other drug |
|------|----------------|------------------------|---------------------------------|
| Aspirin | Irreversible platelet‑aggregator inhibitor | It does not change lipid metabolism; its cardiovascular benefit comes from reducing clot formation. | No pharmacologic or pharmacokinetic interaction that would blunt Vascepa’s lipid‑lowering effect. |
| Vascepa | Highly purified, synthetic eicosapentaenoic acid (EPA) ester | Lowers triglycerides by >30–40 % and modestly lowers LDL (≈5 %) via reduced hepatic VLDL synthesis and increased clearance. | No known effect on aspirin’s antiplatelet action. |
Evidence snapshot
- Clinical trials (e.g., MARINE, MARINE‑EXTEND, STRENGTH) and real‑world studies have routinely used aspirin together with Vascepa in secondary‑prevention populations.
- Pharmacokinetic studies show that aspirin does not change the plasma concentrations of EPA or its metabolites.
- No clinical data indicate a change in triglyceride‑ or LDL‑lowering efficacy when the two drugs are co‑administered.
Things to keep in mind
| Point | What it means for you |
|-------|-----------------------|
| Bleeding risk | Both aspirin and omega‑3 fatty acids can slightly increase bleeding tendency. If you’re taking a high dose of aspirin (≥325 mg) or have a bleeding disorder, talk to your clinician about monitoring. |
| Dosage | Vascepa is usually prescribed as 2 g taken twice daily (4 g total). Aspirin’s dose depends on the indication (e.g., 81 mg daily for primary prevention, 325–650 mg for secondary). |
| Other medications | If you’re on statins, fibrates, or other lipid‑lowering agents, the combination is often well‑tolerated. |
| Lifestyle | Diet and exercise still play a huge role; the drugs are adjuncts, not replacements. |
Bottom line
If you’re prescribed both aspirin and Vascepa for cardiovascular protection, there is no evidence that aspirin interferes with Vascepa’s ability to lower triglycerides or LDL cholesterol. As always, keep up with follow‑up labs and discuss any new symptoms with your prescriber.